Our People
We bring experienced medical, oncology market research and analysis, and management consulting expertise to bear on client issues. Some of our key team members include:
-
Jeff Forringer — President
Jeff was appointed President in January 2009 and leads IntrinsiQ's Pharmaceutical, Financial and IntelliDose businesses. Jeff's twenty years of experience in pharmaceutical information includes tenures at IMS, Datamonitor and Consumer Health Science. He also has worked in the international marketplace, notably executing pharmaceutical sales in Japan.
Jeff has a degree in history from the SUNY Buffalo.
-
Mike Raquet — Business Development
Mike leads the development of new advisory boards and new data and consulting services offerings to enhance the knowledge and understanding of oncology treatment.
He has spent over 25 years associated with the Pharmaceutical industry in many different areas including clinical, marketing, sales, and manufacturing. Mike has held senior-level positions at IMS Health, PRA International, and Tunnell Consulting. Most recently he was president of ClientAlignment Inc, a consulting firm specializing in improving business development.
Mike holds an MBA from Boston University and a BS from Villanova University.
-
Maria L. Rugani — General Manager, Pharmaceutical Data Division
Maria manages the data, analysis, and consulting service offerings of IntrinsiQ. She brings extensive experience in market research for cancer treatment and cancer supportive care. Her healthcare consulting experience includes creating marketing and sales strategies for product launches and developing pricing and reimbursement strategies for products in development. In her career, she also managed secondary data analysis in market planning at a leading biotech oncology company. Maria joined IntrinsiQ with its acquisition of WWMR, a leading primary research firm.
Maria holds an MBA from Carnegie-Mellon University and a degree in chemistry from Occidental College.
-
Rich Gray — General Manager, IntelliDose Division
Rich Gray leads the IntelliDose oncology clinical information software division of IntrinsiQ. He directs sales and marketing, product management, professional services, and account management. Rich brings over 25 years of healthcare information technology sales and management experience. Prior to joining IntrinsiQ, Rich served in both domestic and international sales roles at MEDITECH, and was Vice President of Sales and Marketing at MSM, Inc. prior to its acquisition by Picis.
Rich is a Registered Pharmacist with a B.S. in Pharmacy from the Massachusetts College of Pharmacy, Boston.
-
Steve Hamann — Vice President of Technology
As the Vice President of Technology Steve is responsible for the IntelliDose software delivery team as well as the data warehouse operations that support the Intrinsiq analytics business.
Steve has over 13 years experience in the design and delivery of software in the health care, medical insurance and manufacturing industries. Prior to the joining IntrinsiQ, he held technical leadership roles as a consultant for IBM Global Services, Accenture and Molecular, Inc. in Watertown, MA.
Steve is a graduate of Bentley University in Waltham, Massachusetts.
-
Robert Weisman — Director of Finance
Rob joined IntrinsiQ in March 2007 as Controller. In January 2009 he was promoted to Director of Finance, in charge of the Finance and Accounting functions as well as Human Resources and Administration. He spent almost 10 years at ISI Emerging Markets, joining as an intern in the Accounting Department, and leaving as their Controller, and most recently was the Controller at Sports Loyalty Systems.
Rob holds a MBA from NYU’s Stern School of Business and a BS from Boston College.
-
Andrew Scott — Director, Product Management
Andrew leads the product development initiatives for IntelliDose setting product strategy, managing the product roadmap and releases of the product to the market. Prior to his current role, Andrew spent four years as a clinical specialist at IntelliDose building a wealth of knowledge on the use of IntelliDose and technology in the oncology setting. He is a registered nurse and has practiced in oncology and bone marrow transplant in the UK and the US. Andrew also holds a degree in business management.
Andrew is a graduate of Surrey University and Bath University both in England, United Kingdom.